About this medicine

Auvelity is a US brand of a tablet containing dextromethorphan and bupropion. It is used in the US for adult depression and agitation linked to dementia due to Alzheimer’s disease.

No current UK Auvelity product was identified in the MHRA public sources checked on 15 November 2026. This search finding is not proof that all supply routes are unavailable. Ask your pharmacist or prescriber to confirm current UK licensing, supply and alternatives.

This page explains the medicine and its safety information using the US product label. US approval does not establish UK approval or routine NHS availability.

What is this medicine used for?

In the US, Auvelity is approved for major depressive disorder in adults. It is also approved for agitation associated with dementia due to Alzheimer’s disease. It is taken regularly for agitation, not as an as-needed rescue medicine. These are US indications.

A UK prescriber considering an unlicensed medicine must explain why a suitable licensed option would not meet the person’s needs, discuss benefits and risks, and arrange follow-up. This page does not establish that Auvelity can be obtained or funded in the UK.

Which warning signs need help?

Antidepressants can increase suicidal thoughts and actions in people aged 24 and younger, especially early in treatment or after a dose change. People of every age need follow-up for worsening mood or unusual changes in behaviour. Auvelity is not approved for children.

Get emergency help for a seizure, trouble breathing, facial or throat swelling, or a suspected overdose. If a seizure occurs, stop taking Auvelity and do not restart it.

Seek urgent medical help for fever with agitation or confusion, sweating, a fast heartbeat, muscle stiffness or shaking. These can be signs of serotonin syndrome, a dangerous reaction involving the chemical messenger serotonin.

Contact your prescriber immediately for new or worsening suicidal thoughts, unusual behaviour, or feeling very energised with little need for sleep. If you cannot stay safe, get emergency help.

Sudden eye pain or vision changes need urgent care. Severe confusion, weakness, unsteadiness or a seizure can also signal low sodium in the blood.

How do I take it safely?

The US product is an extended-release tablet taken by mouth. It has different starting instructions for depression and Alzheimer’s-related agitation. US strengths and schedules are not a UK prescribing guide.

If a clinician arranges treatment, follow the directions for the exact product supplied. The US Auvelity label says to swallow tablets whole, with or without food; do not split, crush or chew them. Some people need a lower dosing frequency because of other medicines, kidney function or how their body breaks down the ingredients.

What side effects should I know about?

Dizziness, sleepiness or headache. Wait to drive until you know how the medicine affects you, and take care to prevent falls.

Dry mouth, diarrhoea, sweating or sexual side effects can occur. In the Alzheimer’s agitation study, dizziness and indigestion were the most common effects meeting the label’s reporting threshold.

Who needs extra care with this medicine?

A contraindication is a medical reason a medication should not be used in a particular situation.

Do not take it if you have a seizure disorder, current or past anorexia nervosa or bulimia, or an allergy to either ingredient. It must not be used during sudden withdrawal from alcohol, benzodiazepines, barbiturates or seizure medicines. Ask for help with a safe plan if you need to stop any of these.

Do not combine it with an MAOI, a type of medicine used for some mental health conditions. A gap of at least 14 days is required in either direction when switching with an MAOI antidepressant. Linezolid and intravenous methylene blue also have MAOI effects; tell anyone treating you that you take Auvelity.

Your care team should check blood pressure and ask about any personal or family history of bipolar disorder before treatment. Blood pressure should be checked during treatment too. Tell them about kidney or liver problems, head injury, low sodium, falls or narrow-angle glaucoma, an eye condition.

Can it affect my other medicines?

Check with your pharmacist before adding cough or cold remedies: many contain dextromethorphan. Other bupropion products, including Wellbutrin, can also duplicate an ingredient. Do not combine these on your own.

Other antidepressants and medicines that affect serotonin can raise the risk of serotonin syndrome. Medicines that increase seizure risk, change drug breakdown, or affect dopamine need review. Auvelity can also change levels of medicines such as digoxin. Bring a complete medicine and supplement list.

Avoid or minimise alcohol. If you drink heavily, do not stop suddenly without medical advice because withdrawal can increase seizure risk.

What check-ups will I need?

Your care team should check blood pressure before and during treatment, review other medicines and ask about bipolar disorder. Follow-up should look at mood or agitation, side effects, falls and whether treatment is helping. Report sudden changes promptly rather than waiting for the next appointment.

What about pregnancy, breastfeeding and age?

Auvelity may harm an unborn baby. If you become pregnant, contact your prescriber promptly to arrange stopping and an alternative treatment. Discuss pregnancy plans before starting. Breastfeeding is not recommended during treatment or for five days after the final dose. It is not approved for children.

What if I miss a dose or want to stop?

For the US Auvelity product, a missed dose should be skipped. Take the next dose at the usual time and do not take an extra dose. If you have been supplied a medicine through an individual prescribing arrangement, confirm its instructions with your pharmacist. Discuss stopping with your prescriber.

How does it work?

Brain cells communicate through chemical messages. Dextromethorphan changes activity at sites called NMDA and sigma-1 receptors, which help cells receive and respond to signals. Bupropion affects the messengers norepinephrine and dopamine. It also slows the breakdown of dextromethorphan, helping it stay in the body longer. Researchers do not yet know exactly how these actions relieve depression or agitation.

How does it affect my body?

Pharmacodynamics is the medical term for what a medication does to the body.

The intended benefits are less depression or less Alzheimer’s-related agitation. Effects on alertness, blood pressure and mood also explain why follow-up matters.

How does my body process it?

Pharmacokinetics is the medical term for how your body absorbs, breaks down, and removes a medication.

The liver breaks down both ingredients. Bupropion slows a liver enzyme called CYP2D6, which normally breaks down dextromethorphan. Some people naturally have less activity of this enzyme. They, people taking strong CYP2D6 blockers, and those with moderately reduced kidney function need a lower dosing frequency. Severe kidney or liver disease may make Auvelity unsuitable.

How do treatment options differ?

Auvelity contains bupropion, but it is a separate combination product. Taking bupropion alone or adding a cough medicine yourself is not an equivalent treatment. Ask your prescriber about the benefits and risks of each option.

A closer look at the science

This tablet contains two distinct active substances. A single chemical structure would not represent both ingredients. Dextromethorphan is supplied as its hydrobromide salt and bupropion as its hydrochloride salt.

How was this medicine developed?

The FDA first approved Auvelity in 2022 for major depressive disorder in adults. It combined two existing ingredients in a single tablet designed for this use. In a six-week depression study, the group taking Auvelity improved more than the group taking a placebo, a tablet without active medicine.

A difference was seen at the first weekly assessment, but this does not mean everyone feels better within a week. In April 2026, the FDA added approval for agitation associated with dementia due to Alzheimer’s disease. That decision followed studies of agitation symptoms and the return of symptoms after treatment withdrawal.

The two uses have different starting instructions. Neither approval establishes a UK product licence.

Sources and References

  1. Auvelity: FDA prescribing information and Medication Guide
  2. Auvelity: current product label
  3. Dextromethorphan and bupropion: patient information
  4. FDA approval of Auvelity for agitation associated with Alzheimer’s dementia
  5. GEMINI depression study: design and results
  6. MHRA medicine product information search
  7. MHRA authorised product category lists

    Scope: United Kingdom.

  8. Marketing authorisations granted in 2026

    Scope: United Kingdom.

  9. Prescribing off-label or unlicensed medicines: responsibilities

    Scope: United Kingdom.

  10. Serotonin syndrome: MedlinePlus Medical Encyclopedia
  11. Monitoring a person during and after antidepressant switching – NHS SPS - Specialist Pharmacy Service – The first stop for professional medicines advice

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top